AW 31071 RAA hs Disclaimer Eurotech reserves the right to make changes in specifications and other information contained within this document without prior notice and the reader should in all cases consult Eurotech to determine whether any such changes have been made The information in this publication does not represent a commitment on the part of Eurotech Eurotech shall not be liable for technical or editorial errors or omissions contained
volution in mobile conri Disclaimer Eurotech reserves the right to make changes in specifications and other information contained within this document without prior notice and the reader should in all cases consult Eurotech to determine whether any such changes have been made The information in this publication does not represent a commitment on the part of Eurotech Eurotech shall not be liable for technical or editorial errors or omissions contained herein nor for inc
ALLEGATO I RIASSUNTO DELLE CARATTERISTICHE DEL PRODOTTO 1 DENOMINAZIONE DEL MEDICINALE ZYPADHERA 210 mg polvere e solvente per sospensione iniettabile a rilascio prolungato 2 COMPOSIZIONE QUALITATIVA E QUANTITATIVA Ogni flaconcino contiene olanzapina pamoato monoidrato corrispondente a 210 mg di olanzapina Dopo ricostituzione ogni ml di sospensione contiene 150 mg di olanzapina Per l elenco completo degli eccipienti vedere paragrafo 6 1 3 FORMA FARMACEUTICA P